Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Stanford University School of Medicine adopts new, industry-funded model for continuing physicians’ education

Stanford University School of Medicine has developed a new, industry-funded model for the continuing education of physicians that aims to improve patient care while ensuring that corporate donors do not exert influence over the curriculum.

12 Jan 2010

American Heart Association encourages more Americans to get vaccinated against H1N1

The American Heart Association supports National Influenza Vaccination Week, Jan. 10-16, an effort led by the Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) to encourage more Americans to get vaccinated against H1N1.

12 Jan 2010

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardipine hydrochloride) is significantly more effective than intravenous labetalol for the management of blood pressure (BP) in stroke patients.

12 Jan 2010

American Heart Association supports salt reduction initiative

The American Heart Association (AHA) applauds the efforts of New York City to work with the packaged and restaurant foods industry to reduce the amount of salt in the food supply. These efforts serve an important role in bringing both the public health community and food industry together to create solutions and help Americans live healthier lives.

12 Jan 2010

ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled “Methods for Treatment with Bucindolol Based on Genetic Targeting.” The Notice of Allowance is the USPTO’s official communication that the examination of the patent application has been successfully completed and that a patent will be issued.

12 Jan 2010

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

A growth factor that is a common target of cancer drugs also plays an important role in the heart's response to stress, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Journal of Clinical Investigation.

12 Jan 2010

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has joined with Gust Bardy, MD to create an innovation center focused on the development and commercialization of simple, cost-effective medical products and services that positively impact public health.

11 Jan 2010

Yale - New Haven Hospital earns SCPC accreditation

The Society of Chest Pain Centers (www.SCPCP.org), an international non-profit focused on improving care for cardiac patients, has announced that Yale - New Haven Hospital has earned the SCPC accreditation in recognition of its ability to quickly determine and intervene when a patient is experiencing cardiac symptoms.

9 Jan 2010

Abiomed announces preliminary third quarter fiscal 2010 revenue

Abiomed, Inc., a leading provider of breakthrough heart support technologies designed for heart recovery, today announced preliminary third quarter fiscal 2010 revenue of approximately $22.8 million, up 32% compared to revenue of $17.3 million for the same period of fiscal 2009.

8 Jan 2010

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

7 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

BUSM researchers develop mathematical methodology to reduce biologic variation in clinical status

Clinicians rely on laboratory tests to monitor the progression or remission of disease, or to identify pathologic alterations in physiology that may precede clinical events. Monitoring quantitative laboratory results represents a crucial component in the assessment of response to therapy.

7 Jan 2010

Educational sessions and special workshops highlight advancements in molecular imaging

SNM's Conjoint Mid-Winter Meetings, Jan. 27-Feb. 2, 2010, in Albuquerque, N.M., will bring together four scientific meetings under one umbrella. The meeting, which provides attendees with the opportunity to earn up to 25 continuing education credits, will highlight the latest advancements in molecular imaging and nuclear medicine. The educational sessions will conclude with special workshops on nanomedicine and clinical trials.

7 Jan 2010

EPO grants notice of allowance for Response Biomedical’s ‘Fong Patent’

Response Biomedical Corporation announced today that the Company has received a Notice of Allowance from the European Patent Office for the patent entitled “Sensitive Immunochromatographic Assay”, referred to as the “Fong Patent”.

7 Jan 2010

The Methodist Hospital offers web-based tool to help patients understand their health care better

The interactive program from Emmi Solutions describes and illustrates upcoming procedures for patients to help educate them on procedures such as cardiac bypass or knee replacement. It also helps patients understand how to manage chronic conditions like diabetes or heart failure.

7 Jan 2010

Researchers identify new approach to eliminate side effects of drugs

Researchers at the Stanford University School of Medicine have taken an early step toward identifying a new approach to drug discovery that may eventually yield drugs with fewer side effects.

7 Jan 2010

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced the first implantations of BIOTRONIK’s new leadless cardiac monitoring device performed by a team of physicians led by Professor Dr. Gerhard Hindricks, Director, Electrophysiology Department at the Leipzig Heart Center in Leipzig, Germany.

6 Jan 2010

New survival prediction equation may impact clinical trials for treating PAH

Setting out to determine the survival of patients with pulmonary arterial hypertension (PAH), researchers at the University of Chicago Medical Center and their colleagues also discovered that an equation used for more than 20 years to predict survival is outdated.

6 Jan 2010

Animal experiments show old antidepressant may reverse heart failure

A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

6 Jan 2010

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

Bioheart, Inc. announced today that the company has signed distribution agreements with Restoration Medical, McRay Medical, Alamo Scientific and Morey Medical. These distributors will assist Bioheart with introducing its Home Heart Failure Monitoring Systems to physicians and hospitals throughout the United States.

6 Jan 2010

Heart Failure News and Research

Further Reading

Stanford University School of Medicine adopts new, industry-funded model for continuing physicians’ education

American Heart Association encourages more Americans to get vaccinated against H1N1

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

American Heart Association supports salt reduction initiative

ARCA biopharma to receive US patent for methods of heart failure treatment with genetic testing based bucindolol

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Yale - New Haven Hospital earns SCPC accreditation

Abiomed announces preliminary third quarter fiscal 2010 revenue

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

BUSM researchers develop mathematical methodology to reduce biologic variation in clinical status

Educational sessions and special workshops highlight advancements in molecular imaging

EPO grants notice of allowance for Response Biomedical’s ‘Fong Patent’

The Methodist Hospital offers web-based tool to help patients understand their health care better

Researchers identify new approach to eliminate side effects of drugs

Physicians perform first implantation of leadless cardiac monitoring device for detecting arrhythmias

New survival prediction equation may impact clinical trials for treating PAH

Animal experiments show old antidepressant may reverse heart failure

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News